Cato Podcast Rethinking How America Treats Opioid Addiction
10 snips
May 5, 2026 Helen Redmond, Harlem filmmaker, journalist, and licensed clinical social worker with 20+ years working with people with substance use disorder, discusses how methadone clinics feel carceral and trace back to Nixon-era crime control. She explores DEA influence, racialized access between methadone and buprenorphine, COVID-era take-home rules, and international alternatives to current U.S. treatment models.
AI Snips
Chapters
Books
Transcript
Episode notes
Methadone Clinics Operate Like Opioid Treatment Prisons
- Methadone clinics function with a prison-like power differential where staff control access to medication.
- Patients undergo supervised urines, watched ingestion through bulletproof plexiglass, and face rules that can deny doses, creating constant anxiety.
Nixon Era Origins Made Methadone A Crime Control Tool
- The OTP system was shaped in the Nixon era as a crime-control measure targeting urban communities, not purely a medical program.
- Policymakers framed methadone as a way to lower crime tied to heroin in cities, reflecting racialized policing logic.
Fentanyl Necessitates Higher Methadone Doses
- Fentanyl has changed induction and dosing: methadone (a full agonist) is often more effective than buprenorphine for fentanyl-dependent patients.
- Programs must start at higher methadone doses or patients may not return, highlighting clinical realities of the fentanyl era.
